Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy
NCT02292472
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
69
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertrophy of Masseter Muscle
Interventions
DRUG:
Botulinum Toxin Type A
DRUG:
Placebos
Sponsor
Medy-Tox